GHRS vs. SEEL
Compare and contrast key facts about GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GHRS or SEEL.
Key characteristics
| GHRS | SEEL | |
|---|---|---|
| YTD Return | 56.72% | -99.70% |
| 1Y Return | 24.18% | -99.89% |
| 3Y Return (Ann) | -26.70% | -95.99% |
| Sharpe Ratio | 0.23 | -0.55 |
| Sortino Ratio | 0.82 | -3.79 |
| Omega Ratio | 1.10 | 0.58 |
| Calmar Ratio | 0.19 | -1.00 |
| Martin Ratio | 0.59 | -1.11 |
| Ulcer Index | 26.21% | 89.94% |
| Daily Std Dev | 68.72% | 181.09% |
| Max Drawdown | -81.15% | -100.00% |
| Current Drawdown | -67.42% | -100.00% |
Fundamentals
| GHRS | SEEL | |
|---|---|---|
| Market Cap | $476.06M | $418.32K |
| EPS | -$0.67 | $351.04 |
| Total Revenue (TTM) | $80.00K | $1.61M |
| Gross Profit (TTM) | -$156.00K | $1.56M |
| EBITDA (TTM) | -$32.87M | -$17.16M |
Correlation
The correlation between GHRS and SEEL is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GHRS vs. SEEL - Performance Comparison
In the year-to-date period, GHRS achieves a 56.72% return, which is significantly higher than SEEL's -99.70% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GHRS vs. SEEL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GH Research PLC (GHRS) and Seelos Therapeutics, Inc. (SEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GHRS vs. SEEL - Dividend Comparison
Neither GHRS nor SEEL has paid dividends to shareholders.
Drawdowns
GHRS vs. SEEL - Drawdown Comparison
The maximum GHRS drawdown since its inception was -81.15%, smaller than the maximum SEEL drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for GHRS and SEEL. For additional features, visit the drawdowns tool.
Volatility
GHRS vs. SEEL - Volatility Comparison
The current volatility for GH Research PLC (GHRS) is 16.58%, while Seelos Therapeutics, Inc. (SEEL) has a volatility of 52.56%. This indicates that GHRS experiences smaller price fluctuations and is considered to be less risky than SEEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GHRS vs. SEEL - Financials Comparison
This section allows you to compare key financial metrics between GH Research PLC and Seelos Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities